22 research outputs found
CDX2 expression in the hematopoietic lineage promotes leukemogenesis via TGFβ inhibition
The intestine-specific caudal-related homeobox gene-2 (CDX2) homeobox gene, while being a tumor suppressor in the gut, is ectopically expressed in a large proportion of acute leukemia and is associated with poor prognosis. Here, we report that turning on human CDX2 expression in the hematopoietic lineage of mice induces acute monoblastic leukemia, characterized by the decrease in erythroid and lymphoid cells at the benefit of immature monocytic and granulocytic cells. One of the highly stimulated genes in leukemic bone marrow cells was BMP and activin membrane-bound inhibitor (Bambi), an inhibitor of transforming growth factor-β (TGF-β) signaling. The CDX2 protein was shown to bind to and activate the transcription of the human BAMBI promoter. Moreover, in a leukemic cell line established from CDX2-expressing mice, reducing the levels of CDX2 or Bambi stimulated the TGF-β-dependent expression of Cd11b, a marker of monocyte maturation. Taken together, this work demonstrates the strong oncogenic potential of the homeobox gene CDX2 in the hematopoietic lineage, in contrast with its physiological tumor suppressor activity exerted in the gut. It also reveals, through BAMBI and TGF-β signaling, the involvement of CDX2 in the perturbation of the interactions between leukemia cells and their microenvironment
Intra-Aortic Clusters Undergo Endothelial to Hematopoietic Phenotypic Transition during Early Embryogenesis
Intra-aortic clusters (IACs) attach to floor of large arteries and are considered to have recently acquired hematopoietic stem cell (HSC)-potential in vertebrate early mid-gestation embryos. The formation and function of IACs is poorly understood. To address this issue, IACs were characterized by immunohistochemistry and flow cytometry in mouse embryos. Immunohistochemical analysis revealed that IACs simultaneously express the surface antigens CD31, CD34 and c-Kit. As embryos developed from 9.5 to 10.5 dpc, IACs up-regulate the hematopoietic markers CD41 and CD45 while down-regulating the endothelial surface antigen VE-cadherin/CD144, suggesting that IACs lose endothelial phenotype after 9.5 dpc. Analysis of the hematopoietic potential of IACs revealed a significant change in macrophage CFC activity from 9.5 to 10.5 dpc. To further characterize IACs, we isolated IACs based on CD45 expression. Correspondingly, the expression of hematopoietic transcription factors in the CD45(neg) fraction of IACs was significantly up-regulated. These results suggest that the transition from endothelial to hematopoietic phenotype of IACs occurs after 9.5 dpc
L' enzyme de conversion de l'angiotensine (ACE) dans l'ontogenèse du systeme hématopoïetique de l'embryon et du foetus humains
PARIS7-Bibliothèque centrale (751132105) / SudocSudocFranceF
Le système rénine-angiotensine (SRA) dans l'émergence hématopoïétique au cours de l'ontogenèse
Nous avons montré que l'enzyme de conversion de l'angiotensine (ACE) est un nouveau marqueur de la cellule souche hématopoïétique et identifie l émergence de l'hématopoïèse dans tous les sites hématogènes de l embryon humain. L'ACE fait partie du système rénine-angiotensine (SRA) dont la fonction principale est d'agir sur l'angiotensine I pour former l'angiotensine II (AngII), un puissant vasoconstricteur.De plus, nous montrons que les principaux composants du SRA (les récepteurs AT1 et AT2, l angiotensinogène et la rénine) sont exprimés dans la même région de l'embryon qui exprime l'ACE, suggérant ainsi l existence d un SRA local dans l'embryon précoce. Des tests fonctionnels, conduits in vitro chez l'embryon de la souris, montrent que l Ang II stimule dans la culture l'émergence des progéniteurs hématopoïétiques, effet qui peut être bloqué par un antagoniste spécifique de l AT1. Ces observations suggèrent pour la première fois, le rôle direct du SRA dans l émergence hématopoïétique au cours de l ontogenèse. De plus, nous mettons en évidence l'existence d'un SRA local dans la moelle osseuse (MO) adulte et nous montrons que les principaux éléments de ce système sont surexprimés dans la MO de patients atteints de leucémie aiguë myéloïde, aussi bien dans les blastes que dans les cellules stromales. Ces observations suggèrent une contribution du SRA à la dérégulation de la niche observée dans les hémopathies.Ainsi, la présence d un SRA local dans la niche hématopoïétique intra-embryonnaire et dans la MO chez l adulte place ce système dans une position stratégique comme acteur important de l émergence et de la régulation du système sanguin définitif.We have shown that the angiotensin-converting enzyme (ACE) is a new marker of human hematopoietic stem cells and also identifies emerging hematopoiesis in all hemogenic sites inside the human embryo. ACE is a key component of renin-angiotensin system (RAS) as it catalyses the production of angiotensin II (Ang II) well known for its effect in the control of blood pressure, through AT1 and AT2 receptors.Furthermore, we observe the presence of the main elements of the RAS (AT1, AT2 receptors, angiotensinogen and renin) in the same region of the embryo expressing ACE, meaning that a local RAS exists in the embryo. Functional in vitro analyses, carried out in mouse model, show a stimulatory effect of AngII in the hematopoietic precursors emergence, an effect inhibited by a specific AT1 antagonist. These observations suggest for the first time a direct role of RAS in the emergence of hematopoiesis during ontogeny. In addition, our data indicate the presence of a local RAS inside the adult bone marrow (BM). This system is overexpressed in the BM of acute myeloid leukemia (AML) patients, both in hematopoietic cells and in stromal cells suggesting a RAS contribution to the bone marrow niche deregulation, always observed in these hemopathies.Therefore, the existence of a local RAS in the intraembryonic niche and in the adult bone marrow suggests that this system is an important actor in the emergence and regulation of the definitive blood system.STRASBOURG-Bib.electronique 063 (674829902) / SudocSudocFranceF
Identification d'une population atypique de cellules mésenchymateuses du foie humain (Modulation de leurs potentialités par les cytokératines 8 et 18)
LE KREMLIN-B.- PARIS 11-BU Méd (940432101) / SudocSudocFranceF
Blood Vessel Resident Human Stem Cells in Health and Disease
The vascular wall is comprised of distinct layers controlling angiogenesis, blood flow, vessel anchorage within organs, and cell and molecule transit between blood and tissues. Moreover, some blood vessels are home to essential stem-like cells, a classic example being the existence in the embryo of hemogenic endothelial cells at the origin of definitive hematopoiesis. In recent years, microvascular pericytes and adventitial perivascular cells were observed to include multi-lineage progenitor cells involved not only in organ turnover and regeneration but also in pathologic remodeling, including fibrosis and atherosclerosis. These perivascular mesodermal elements were identified as native forerunners of mesenchymal stem cells. We have presented in this brief review our current knowledge on vessel wall-associated tissue remodeling cells with respect to discriminating phenotypes, functional diversity in health and disease, and potential therapeutic interest
Renin-angiotensin system is involved in embryonic emergence of hematopoietic stem/progenitor cells
International audienceAbstract Angiotensin-converting enzyme (ACE), a key element of the renin-angiotensin system (RAS), has recently been identified as a new marker of both adult and embryonic human hematopoietic stem/progenitor cells (HSPCs). However, whether a full renin-angiotensin pathway is locally present during the hematopoietic emergence is still an open question. In the present study, we show that this enzyme is expressed by hematopoietic progenitors in the developing mouse embryo. Furthermore, ACE and the other elements of RAS—namely angiotensinogen, renin, and angiotensin II type 1 (AT1) and type 2 (AT2) receptors—are expressed in the paraaortic splanchnopleura (P-Sp) and in its derivative, the aorta-gonad-mesonephros region, both in human and mouse embryos. Their localization is compatible with the existence of a local autocrine and/or paracrine RAS in these hemogenic sites. in vitro perturbation of the RAS by administration of a specific AT1 receptor antagonist inhibits almost totally the generation of blood CD45-positive cells from dissected P-Sp, implying that angiotensin II signaling is necessary for the emergence of hematopoietic cells. Conversely, addition of exogenous angiotensin II peptide stimulates hematopoiesis in culture, with an increase in the number of immature c-Kit+CD41+CD31+CD45+ hematopoietic progenitors, compared to the control. These results highlight a novel role of local-RAS during embryogenesis, suggesting that angiotensin II, via activation of AT1 receptor, promotes the emergence of undifferentiated hematopoietic progenitors
Primitive macrophages control HSPC mobilization and definitive haematopoiesis
International audienceIn vertebrates, haematopoietic stem/progenitor cells (HSPCs) first emerge in the aorta-gonad-mesonephros (AGM) before colonizing transitory and subsequently definitive haematopoietic organs allowing haematopoiesis throughout adult life. Here we identify an unexpected primitive macrophage population accumulated in the dorsal mesenteric mesoderm surrounding the dorsal aorta of the human embryo and study its function in the transparent zebrafish embryo. Our study reveals dynamic interactions occurring between the HSPCs and primitive macrophages in the AGM. Specific chemical and inducible genetic depletion of macrophages or inhibition of matrix metalloproteinases (Mmps) leads to an accumulation of HSPCs in the AGM and a decrease in the colonization of haematopoietic organs. Finally, in vivo zymography demonstrates the function of primitive macrophages in extracellular matrix degradation, which allows HSPC migration through the AGM stroma, their intravasation, leading to the colonization of haematopoietic organs and the establishment of definitive haematopoiesis